Health In Tech, Inc.

2.8500+0.12 (+4.4%)

Oct 28, 4:00:00 PM EDT · NasdaqCM · HIT · USD

Upcoming Earnings

Report date

Nov 3, 2025 (in 5 days)

Key Stats

Market Cap

160.91M

P/E (TTM)

142.50

Basic EPS (TTM)

0.02

Dividend Yield

Recent Filings

8-K

Annual meeting approves directors, plan

10/6/25Oct 6, 2025

Health In Tech, Inc. held its 2025 Annual Meeting on October 3, 2025, where shareholders re-elected all five directors with overwhelming support, approving 147-148 million votes for each nominee amid 1.87 million broker non-votes. They also approved amending the 2024 Equity Incentive Plan to boost authorized Class A shares by 3 million to 10.68 million and add 2 million Class B shares for executive options, passing 147.8 million for versus 217,556 against. Auditors MaloneBailey, LLP were ratified nearly unanimously. Directors stay steady.

8-K

Execs awarded Initiative-tied RSAs

9/29/25Sep 29, 2025

Health In Tech's board approved restricted stock awards of 80,000 shares each to CEO Tim Johnson and CFO Linlin Qian on September 24, 2025, tied to their work on a new Initiative. Vesting occurs in thirds over 12-month periods starting from signing a letter of intent, proof-of-concept or beta launch, and full commercial rollout. This equity incentive aligns executive efforts with Initiative milestones. Grants follow the company's Equity Incentive Plan.

8-K

Execs awarded program-linked stock

8/19/25Aug 19, 2025

Health In Tech's board approved restricted stock awards to CEO Tim Johnson, CFO Linlin Qian, and CTO Imran Yousuf on August 15, 2025, to incentivize development of two new programs. Johnson gets 34,000 shares total, Qian 27,000, and Yousuf 7,000, vesting in monthly installments over 12 months per program upon successful marketplace launch. This ties executive rewards directly to program rollout success. Vesting hinges on operational milestones.

10-Q

Q2 FY2025 results

8/8/25Aug 8, 2025

Health In Tech posted solid Q2 FY2025 results, with revenues hitting $9.3M, up 86% year-over-year and 35% quarter-over-quarter (derived), fueled by a 30% jump in enrolled employees to 24,839 and strong SMR fees at $7.2M. Gross margins held steady at 67.7%, while operating income rose to $0.7M from $0.5M in Q1, reflecting disciplined costs amid scaling. Cash climbed to $8.1M, with operating cash flow at $2.0M for the half-year; free cash flow not disclosed in the 10-Q. The March 2025 purchase of $17.4M in deferred administrative surplus for $3.5M bolsters collections potential. Yet competition from larger insurers could squeeze margins if pricing pressures mount.

8-K

COO termination announced

7/28/25Jul 28, 2025

Health In Tech terminated Chris Kurtenbach's at-will employment as Chief Operating Officer on July 22, 2025. The board's abrupt move leaves operational leadership in flux, with no interim arrangements or successor named. This shift could disrupt execution amid the company's emerging growth phase.

About

Health In Tech, Inc. operates as an insurance technology platform company. The company offers reference-based pricing, group insurance captives, community health plans, and association health programs for small businesses; and enhance do it yourself benefit system (eDIYBS), a web-based SaaS quoting platform to quote health insurance for small and medium sized employers. It also provides health intelligence (HI) card to streamline the management of medical records and claims; and HI performance network, which offers a series of hospital facilities, as well as delivers medicare-based reimbursement pricing. Health In Tech, Inc. was founded in 2014 and is headquartered in Stuart, Florida.

CEO

Mr. Tim Johnson

IPO

12/23/2024

Website

https://healthintech.com

Employees

Sector

Technology

Industry

Software - Application